Abstract:AIM:To investigate the role of bone marrow-derived endothelial progenitor cells（EPCs） in the angiogenesis of hepatocellular carcinoma（HCC）.METHODS:The bone marrow of HCC mice was reconstructed by transplanting green fluorescent protein（GFP） + bone marrow cells.The concentration of circulating EPCs was determined by colony-forming assays and fluorescence-activated cell sorting.Serum and tissue levels of vascular endothelial growth factor（VEGF） and colony-stimulating factor（CSF） were quantified by enzyme-linked immunosorbent assay.The distribution of EPCs in tumor and tumor-free tissues was detected by immunohistochemistry and real-time polymerase chain reaction.The incorporation of EPCs into hepatic vessels was examined by immunofluorescence and immunohistochemistry.The proportion of EPCs in vessels was then calculated.RESULTS:The HCC model was successful established.The flow cytometry analysis showed the mean percentage of CD133CD34 and CD133VEGFR2 double positive cells in HCC mice was 0.45% ± 0.16% and 0.20% ± 0.09% respectively.These values are much higher than in the sham-operation group（0.11% ± 0.13%,0.05% ± 0.11%,n = 9） at 14 d after modeling.At 21 d,the mean percentage of circulating CD133CD34 and CD133VEGFR2 cells is 0.23% ± 0.19%,0.25% ± 0.15% in HCC model vs 0.05% ± 0.04%,0.12% ± 0.11% in control.Compared to the transient increase observed in controls,the higher level of circulating EPCs were induced by HCC.In addition,the level of serum VEGF and CSF increased gradually in HCC,reaching its peak 14 d after modeling,then slowly decreased.Consecutive sections stained for the CD133 and CD34 antigens showed that the CD133+ and CD34+ VEGFR2 cells were mostly recruited to HCC tissue and concentrated in tumor microvessels.Under fluorescence microscopy,the bone-marrow（BM）-derived cells labeled with GFP were concentrated in the same area.The relative levels of CD133 and CD34 gene expression were elevated in tumors,around 5.0 and 3.8 times that of the tumor free area.In frozen liver sections from HCC mice,cells co-expressing CD133 and VEGFR2 were identified by immunohistochemical staining using anti-CD133 and VEGFR2 antibodies.In tumor tissue,the double-positive cells were incorporated into vessel walls.In immunofluorescent staining.These CD31 and GFP double positive cells are direct evidence that tumor vascular endothelial cells（VECs） come partly from BM-derived EPCs.The proportion of GFP CD31 double positive VECs（out of all VECs） on day 21 was around 35.3% ± 21.2%.This is much higher than the value recorded on day 7 group（17.1% ± 8.9%）.The expression of intercellular adhesion molecule 1,vascular adhesion molecule 1,and VEGF was higher in tumor areas than in tumor-free tissues.CONCLUSION:Mobilized EPCs were found to participate in tumor vasculogenesis of HCC.Inhibiting EPC mobilization or recruitment to tumor tissue may be an efficient strategy for treating HCC.

Renal Cell Carcinoma-Adjacent Tissues Enhance Mobilization and Recruitment of Endothelial Progenitor Cells to Promote the Invasion of the Neoplasm.

Identification and Significance of Mobilized Endothelial Progenitor Cells in Tumor Neovascularization of Renal Cell Carcinoma.

Epithelial cell adhesion molecule is an independent prognostic marker in clear cell renal carcinoma

Culture and Characterization of Circulating Endothelial Progenitor Cells in Patients with Renal Cell Carcinoma

Combination of Stromal-Derived Factor-1Α and Vascular Endothelial Growth Factor Gene-Modified Endothelial Progenitor Cells is More Effective for Ischemic Neovascularization

Vascular Endothelial Growth Inhibitor, a Cytokine of the Tumor Necrosis Factor Family, is Associated With Epithelial-Mesenchymal Transition in Renal Cell Carcinoma.

Intratumoral CXCL13+CD8+T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma

Cooperation Between the Inflammation and Coagulation Systems Promotes the Survival of Circulating Tumor Cells in Renal Cell Carcinoma Patients

Prognostic model for clear-cell renal cell carcinoma based on natural killer cell-related genes.

NK and T cells with a cytotoxic/migratory phenotype accumulate in peritumoral tissue of patients with clear cell renal carcinoma

Endothelial Precursor Cells Promote Angiogenesis in Hepatocellular Carcinoma

Endothelial Progenitor Cells and Neovascularization of Tumors

Mechanism of Endothelial Progenitor Cell Recruitment into Neo-Vessels in Adjacent Non-Tumor Tissues in Hepatocellular Carcinoma

Circulating endothelial progenitor cell: a promising biomarker in clinical oncology

Identification and Clinical Significance of Mobilized Endothelial Progenitor Cells in Tumor Vasculogenesis of Hepatocellular Carcinoma

Possible prognostic and therapeutic significance of c-Kit expression, mast cell count and microvessel density in renal cell carcinoma

CD151 Promotes Cell Metastasis Via Activating TGF-β1/Smad Signaling in Renal Cell Carcinoma

Prognostic role of pigment epithelium-derived factor in clear cell renal cell carcinoma.

Elevated Microrna-185 is Associated with High Vascular Endothelial Growth Factor Receptor 2 Expression Levels and High Microvessel Density in Clear Cell Renal Cell Carcinoma

Expression of chemokine receptor CXCR4 in renal cancer patientsand its regulatory mechanisms

CXCR1 Expression Predicts Benefit from Tyrosine Kinase Inhibitors Therapy in Patients with Metastatic Renal Cell Carcinoma